
zzso zzso in zzso or zzso can drive the inappropriate zzso of the zzso In many cases, zzso cells adapt to become addicted to this zzso zzso zzso for their zzso providing a therapeutic window for zzso growth zzso As a result, zzso of zzso zzso by zzso or zzso zzso is an attractive therapeutic zzso Indeed, the first zzso zzso zzso has now been approved for clinical use, while clinical evaluation of zzso zzso is at an advanced zzso Despite this progress, it is apparent that zzso cells adapt quickly to these new targeted agents so that zzso with acquired resistance can emerge within zzso months of primary zzso One of the major reasons for this is that zzso cells typically respond to zzso or zzso zzso by undergoing a zzso cell cycle arrest rather than zzso Indeed, although zzso of zzso invariably increases the expression of zzso zzso family zzso zzso cells undergo minimal zzso This zzso response may simply provide the cell with the opportunity to adapt and acquire zzso Here we discuss recent studies that demonstrate that combination of zzso or zzso zzso with zzso of zzso zzso proteins is synthetic lethal for zzso zzso zzso This combination effectively zzso the zzso response of zzso and zzso zzso into a striking zzso cell death zzso This not only zzso the primary efficacy of zzso and zzso zzso but delays the onset of acquired resistance to these agents, zzso their combination in the zzso 

This article is part of a themed section on Emerging zzso Aspects in zzso To view the other articles in this section visit zzso 

